

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 5.84032301 |
| 2 | drug catabolic process (GO:0042737) | 5.44541671 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 5.15507540 |
| 4 | complement activation, alternative pathway (GO:0006957) | 5.10552388 |
| 5 | detection of molecule of bacterial origin (GO:0032490) | 5.06482623 |
| 6 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.91744711 |
| 7 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.91744711 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 4.88145920 |
| 9 | regulation of fibrinolysis (GO:0051917) | 4.84093582 |
| 10 | regulation of protein activation cascade (GO:2000257) | 4.83972885 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 4.79532248 |
| 12 | detection of other organism (GO:0098543) | 4.72345625 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69975701 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.68925097 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.68925097 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.68925097 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.68925097 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.68925097 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.68925097 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.65660313 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.65660313 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.63934055 |
| 23 | regulation of complement activation (GO:0030449) | 4.62766547 |
| 24 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.58336176 |
| 25 | detection of bacterium (GO:0016045) | 4.44054933 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.28577327 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.12654155 |
| 28 | cellular extravasation (GO:0045123) | 4.09858404 |
| 29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.09716003 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 4.07689728 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.07689728 |
| 32 | detection of biotic stimulus (GO:0009595) | 4.01709512 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.94133530 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.89899506 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.87510400 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.84063743 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.79719548 |
| 38 | ethanol oxidation (GO:0006069) | 3.78767446 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.76546348 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 3.69604856 |
| 41 | alkaloid metabolic process (GO:0009820) | 3.67113896 |
| 42 | drug metabolic process (GO:0017144) | 3.64010749 |
| 43 | response to peptidoglycan (GO:0032494) | 3.63362290 |
| 44 | negative regulation of B cell mediated immunity (GO:0002713) | 3.63244726 |
| 45 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.63244726 |
| 46 | cellular glucuronidation (GO:0052695) | 3.61632889 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59766767 |
| 48 | response to host immune response (GO:0052572) | 3.59766767 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.58599669 |
| 50 | microglial cell activation (GO:0001774) | 3.56265447 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54730752 |
| 52 | regulation of humoral immune response (GO:0002920) | 3.53747928 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.53686770 |
| 54 | L-phenylalanine metabolic process (GO:0006558) | 3.53686770 |
| 55 | urea metabolic process (GO:0019627) | 3.53682579 |
| 56 | neutrophil activation (GO:0042119) | 3.49937125 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 3.48929615 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48727940 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48628656 |
| 60 | fibrinolysis (GO:0042730) | 3.44826076 |
| 61 | killing of cells of other organism (GO:0031640) | 3.43401319 |
| 62 | disruption of cells of other organism (GO:0044364) | 3.43401319 |
| 63 | protein carboxylation (GO:0018214) | 3.38295124 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.38295124 |
| 65 | glucuronate metabolic process (GO:0019585) | 3.37909041 |
| 66 | uronic acid metabolic process (GO:0006063) | 3.37909041 |
| 67 | neutrophil mediated immunity (GO:0002446) | 3.34369894 |
| 68 | macrophage activation (GO:0042116) | 3.30719253 |
| 69 | response to interleukin-15 (GO:0070672) | 3.30673174 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 3.27992349 |
| 71 | negative regulation of complement activation (GO:0045916) | 3.27204810 |
| 72 | phospholipid efflux (GO:0033700) | 3.26558102 |
| 73 | oxidative demethylation (GO:0070989) | 3.25024307 |
| 74 | acute-phase response (GO:0006953) | 3.23942657 |
| 75 | protein activation cascade (GO:0072376) | 3.23262609 |
| 76 | response to host (GO:0075136) | 3.23176671 |
| 77 | response to host defenses (GO:0052200) | 3.23176671 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23176671 |
| 79 | bile acid and bile salt transport (GO:0015721) | 3.21642872 |
| 80 | respiratory burst (GO:0045730) | 3.20983265 |
| 81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20845298 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 3.17738059 |
| 83 | negative regulation of humoral immune response (GO:0002921) | 3.14467732 |
| 84 | bile acid biosynthetic process (GO:0006699) | 3.13732319 |
| 85 | complement activation (GO:0006956) | 3.13557763 |
| 86 | aromatic amino acid family catabolic process (GO:0009074) | 3.13102920 |
| 87 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.12895452 |
| 88 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.10410504 |
| 89 | leukocyte aggregation (GO:0070486) | 3.07507418 |
| 90 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06450555 |
| 91 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05817205 |
| 92 | cellular response to interleukin-15 (GO:0071350) | 3.03978158 |
| 93 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03723396 |
| 94 | granulocyte activation (GO:0036230) | 3.03701503 |
| 95 | positive regulation of blood coagulation (GO:0030194) | 3.03662341 |
| 96 | positive regulation of hemostasis (GO:1900048) | 3.03662341 |
| 97 | negative regulation of cholesterol transport (GO:0032375) | 3.02713255 |
| 98 | negative regulation of sterol transport (GO:0032372) | 3.02713255 |
| 99 | phenylpropanoid metabolic process (GO:0009698) | 3.00429843 |
| 100 | opsonization (GO:0008228) | 3.00412808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75026599 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.70676713 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.01159989 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.56212293 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.54495426 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33422243 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.99319818 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97996021 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.96327003 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80282573 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.80191879 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77674701 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.73412136 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68124785 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66293436 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.29981376 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22025475 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21506508 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16199450 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05036903 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04885019 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03816485 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99311977 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97123000 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.95052611 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92398484 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81967666 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79426692 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62338342 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62152360 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60397027 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59058562 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58122328 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.53152548 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53030126 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51376939 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48881227 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47746038 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44103816 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44025586 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43965470 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43810963 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41260822 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.40091610 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38153380 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.37857628 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36175348 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35598521 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32602364 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30177131 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29241075 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28282244 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27581907 |
| 54 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26185631 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24390759 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23104180 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22266383 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21895699 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19758259 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17284334 |
| 61 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16558950 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16376882 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12638628 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09767079 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09086748 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08873691 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07723998 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04171765 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04113644 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03741907 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02840974 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01197177 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00748144 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98102381 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97633421 |
| 76 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97373309 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97123684 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96752169 |
| 79 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95998169 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95051574 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90660551 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90505111 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87541495 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86257961 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85633772 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 0.84959954 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84881393 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82462476 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80332988 |
| 90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79543195 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76986183 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76636786 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76590666 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76505578 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76325430 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75960042 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73812969 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73303579 |
| 99 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71678438 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.71096151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.40591490 |
| 2 | MP0003724_increased_susceptibility_to | 4.22837797 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.14122271 |
| 4 | MP0005365_abnormal_bile_salt | 3.37134953 |
| 5 | MP0003195_calcinosis | 3.34115649 |
| 6 | MP0003436_decreased_susceptibility_to | 3.31908226 |
| 7 | MP0005360_urolithiasis | 3.24941271 |
| 8 | MP0003252_abnormal_bile_duct | 3.16525871 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.10602982 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.10393165 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.04548796 |
| 12 | MP0003303_peritoneal_inflammation | 2.73789873 |
| 13 | MP0009785_altered_susceptibility_to | 2.60146146 |
| 14 | MP0002419_abnormal_innate_immunity | 2.52315104 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.43106948 |
| 16 | MP0002132_abnormal_respiratory_system | 2.34922004 |
| 17 | MP0005025_abnormal_response_to | 2.26392392 |
| 18 | MP0000685_abnormal_immune_system | 2.14550268 |
| 19 | MP0001800_abnormal_humoral_immune | 2.07323248 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.88604657 |
| 21 | MP0005387_immune_system_phenotype | 1.86428767 |
| 22 | MP0001790_abnormal_immune_system | 1.86428767 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.83726679 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.83556143 |
| 25 | MP0009764_decreased_sensitivity_to | 1.81424007 |
| 26 | MP0002723_abnormal_immune_serum | 1.78072668 |
| 27 | MP0005451_abnormal_body_composition | 1.71786884 |
| 28 | MP0005671_abnormal_response_to | 1.71619699 |
| 29 | MP0006082_CNS_inflammation | 1.66049360 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.66044952 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.64722848 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.63269383 |
| 33 | MP0001819_abnormal_immune_cell | 1.63136328 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.61639709 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.56353852 |
| 36 | MP0008469_abnormal_protein_level | 1.55862379 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.52639610 |
| 38 | MP0004883_abnormal_blood_vessel | 1.50393075 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.49517726 |
| 40 | MP0008260_abnormal_autophagy | 1.48614958 |
| 41 | MP0000609_abnormal_liver_physiology | 1.47679058 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.44620131 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.42110690 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.40948526 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.36855200 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.33104444 |
| 47 | MP0002405_respiratory_system_inflammati | 1.32775314 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.26947603 |
| 49 | MP0009840_abnormal_foam_cell | 1.26833716 |
| 50 | MP0003868_abnormal_feces_composition | 1.26227333 |
| 51 | MP0005164_abnormal_response_to | 1.26016639 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.25261433 |
| 53 | MP0004381_abnormal_hair_follicle | 1.23761044 |
| 54 | MP0000716_abnormal_immune_system | 1.21202559 |
| 55 | MP0002398_abnormal_bone_marrow | 1.14064237 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.13781783 |
| 57 | MP0005332_abnormal_amino_acid | 1.13185399 |
| 58 | MP0003866_abnormal_defecation | 1.12716316 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.10422928 |
| 60 | MP0003828_pulmonary_edema | 1.09849029 |
| 61 | MP0009763_increased_sensitivity_to | 1.08154838 |
| 62 | MP0003690_abnormal_glial_cell | 1.07093992 |
| 63 | MP0003075_altered_response_to | 1.06973228 |
| 64 | MP0001851_eye_inflammation | 1.05872935 |
| 65 | MP0002722_abnormal_immune_system | 1.02026473 |
| 66 | MP0003763_abnormal_thymus_physiology | 0.99626226 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.98309966 |
| 68 | MP0001545_abnormal_hematopoietic_system | 0.98309966 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.93511955 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.92603388 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.92487155 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.92249108 |
| 73 | MP0002429_abnormal_blood_cell | 0.90590751 |
| 74 | MP0001764_abnormal_homeostasis | 0.90582614 |
| 75 | MP0000858_altered_metastatic_potential | 0.89960408 |
| 76 | MP0004947_skin_inflammation | 0.87684058 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 0.86976053 |
| 78 | MP0005166_decreased_susceptibility_to | 0.86228076 |
| 79 | MP0000604_amyloidosis | 0.85596227 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 0.85529586 |
| 81 | MP0003878_abnormal_ear_physiology | 0.85385832 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 0.85385832 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.85120893 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81471400 |
| 85 | MP0004130_abnormal_muscle_cell | 0.80916133 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.79834947 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.77819776 |
| 88 | MP0003045_fibrosis | 0.76861584 |
| 89 | MP0000598_abnormal_liver_morphology | 0.76790963 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.76560047 |
| 91 | MP0002928_abnormal_bile_duct | 0.75637603 |
| 92 | MP0003011_delayed_dark_adaptation | 0.75012430 |
| 93 | MP0005535_abnormal_body_temperature | 0.73508879 |
| 94 | MP0009278_abnormal_bone_marrow | 0.72605145 |
| 95 | MP0008874_decreased_physiological_sensi | 0.72105724 |
| 96 | MP0001663_abnormal_digestive_system | 0.67731459 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.67227650 |
| 98 | MP0005310_abnormal_salivary_gland | 0.67210184 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.66981246 |
| 100 | MP0000249_abnormal_blood_vessel | 0.66113358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.48380011 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.85268934 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.74097592 |
| 4 | Orchitis (HP:0100796) | 5.22807447 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.14107519 |
| 6 | Myositis (HP:0100614) | 5.13992833 |
| 7 | Complement deficiency (HP:0004431) | 5.06960077 |
| 8 | Optic neuritis (HP:0100653) | 5.05693728 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 5.05693728 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 5.03790632 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 4.94366193 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.67325545 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.53266676 |
| 14 | Joint hemorrhage (HP:0005261) | 4.42664982 |
| 15 | Abnormality of complement system (HP:0005339) | 4.35630857 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 4.28903945 |
| 17 | Gingival bleeding (HP:0000225) | 4.22807355 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.22198339 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 4.15753807 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.99387515 |
| 21 | Hypochromic anemia (HP:0001931) | 3.93144215 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.91803383 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.76617218 |
| 24 | Stomatitis (HP:0010280) | 3.75308256 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.70629128 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.69982660 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.61308624 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.54985302 |
| 29 | Pulmonary embolism (HP:0002204) | 3.45749109 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29024010 |
| 31 | Meningitis (HP:0001287) | 3.28130941 |
| 32 | Glomerulonephritis (HP:0000099) | 3.23846868 |
| 33 | Obstructive lung disease (HP:0006536) | 3.20781161 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20781161 |
| 35 | Gingivitis (HP:0000230) | 3.15405309 |
| 36 | Encephalitis (HP:0002383) | 3.12852240 |
| 37 | Anorexia (HP:0002039) | 3.09513035 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.07474100 |
| 39 | Gangrene (HP:0100758) | 3.04200112 |
| 40 | Recurrent skin infections (HP:0001581) | 3.04056060 |
| 41 | Peritonitis (HP:0002586) | 3.01914013 |
| 42 | Recurrent fungal infections (HP:0002841) | 3.01611634 |
| 43 | Epistaxis (HP:0000421) | 2.99592136 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.95509561 |
| 45 | Thrombophlebitis (HP:0004418) | 2.95247573 |
| 46 | Spontaneous abortion (HP:0005268) | 2.93044789 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87650926 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.87306296 |
| 49 | Vasculitis (HP:0002633) | 2.84666784 |
| 50 | Arterial thrombosis (HP:0004420) | 2.81729480 |
| 51 | Amyloidosis (HP:0011034) | 2.81411421 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.78854970 |
| 53 | Microcytic anemia (HP:0001935) | 2.76536503 |
| 54 | Xanthomatosis (HP:0000991) | 2.75666314 |
| 55 | Hemoptysis (HP:0002105) | 2.73938007 |
| 56 | Urticaria (HP:0001025) | 2.68690695 |
| 57 | Episodic fever (HP:0001954) | 2.54913616 |
| 58 | Purpura (HP:0000979) | 2.53509336 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.50250936 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.50250936 |
| 61 | Osteomalacia (HP:0002749) | 2.49398307 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.47290410 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.46245912 |
| 64 | Increased IgE level (HP:0003212) | 2.45203356 |
| 65 | Joint swelling (HP:0001386) | 2.41295082 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.40491151 |
| 67 | Nephritis (HP:0000123) | 2.39992597 |
| 68 | Menorrhagia (HP:0000132) | 2.35528001 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.33324747 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.32157598 |
| 71 | Chest pain (HP:0100749) | 2.31136533 |
| 72 | Intrahepatic cholestasis (HP:0001406) | 2.28571772 |
| 73 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.26116277 |
| 74 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24579941 |
| 75 | Acne (HP:0001061) | 2.21022194 |
| 76 | Increased serum ferritin (HP:0003281) | 2.20352703 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.15422455 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.11684722 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 2.10977780 |
| 80 | Poikilocytosis (HP:0004447) | 2.09672766 |
| 81 | Arthropathy (HP:0003040) | 2.08637616 |
| 82 | Leukocytosis (HP:0001974) | 2.07280401 |
| 83 | Polycythemia (HP:0001901) | 2.05688142 |
| 84 | Toxemia of pregnancy (HP:0100603) | 2.04773242 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.00651926 |
| 86 | Fat malabsorption (HP:0002630) | 2.00083876 |
| 87 | Acute hepatic failure (HP:0006554) | 1.98181361 |
| 88 | Rickets (HP:0002748) | 1.97838078 |
| 89 | T lymphocytopenia (HP:0005403) | 1.93417309 |
| 90 | Mitral stenosis (HP:0001718) | 1.89499409 |
| 91 | Cellulitis (HP:0100658) | 1.88656967 |
| 92 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.86335771 |
| 93 | Keratitis (HP:0000491) | 1.86066455 |
| 94 | Abnormality of the endocardium (HP:0004306) | 1.85347734 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84404136 |
| 96 | Skin rash (HP:0000988) | 1.83646225 |
| 97 | Abnormality of the peritoneum (HP:0002585) | 1.83047578 |
| 98 | Pustule (HP:0200039) | 1.82419059 |
| 99 | Periodontitis (HP:0000704) | 1.81692857 |
| 100 | Increased mean platelet volume (HP:0011877) | 1.81085956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.17709228 |
| 2 | IRAK4 | 3.46734494 |
| 3 | MAP2K3 | 3.12981358 |
| 4 | ERN1 | 3.09598829 |
| 5 | BLK | 2.99445741 |
| 6 | TYK2 | 2.83504639 |
| 7 | MAP4K1 | 2.82463626 |
| 8 | EPHB1 | 2.52266278 |
| 9 | GRK6 | 2.44282815 |
| 10 | CSK | 2.39362586 |
| 11 | TNK2 | 2.32220654 |
| 12 | FES | 2.07429435 |
| 13 | MAP3K3 | 1.94018149 |
| 14 | ZAP70 | 1.88313969 |
| 15 | TXK | 1.87190481 |
| 16 | TAOK1 | 1.80766439 |
| 17 | TAOK3 | 1.79604410 |
| 18 | IRAK1 | 1.70090263 |
| 19 | JAK2 | 1.60660699 |
| 20 | HCK | 1.59620606 |
| 21 | MAP3K2 | 1.57287833 |
| 22 | SYK | 1.52596436 |
| 23 | MAP3K11 | 1.50862839 |
| 24 | KSR2 | 1.50325548 |
| 25 | FGR | 1.49300914 |
| 26 | PRPF4B | 1.47318755 |
| 27 | BTK | 1.46588577 |
| 28 | YES1 | 1.46249235 |
| 29 | PIK3CG | 1.43917045 |
| 30 | EPHA3 | 1.42536824 |
| 31 | JAK3 | 1.41176693 |
| 32 | IKBKE | 1.41061062 |
| 33 | MAP3K1 | 1.38168700 |
| 34 | MAP2K4 | 1.31594813 |
| 35 | LYN | 1.27793993 |
| 36 | JAK1 | 1.26982491 |
| 37 | FRK | 1.22492378 |
| 38 | MAP3K6 | 1.14854424 |
| 39 | FGFR3 | 1.12234242 |
| 40 | FGFR4 | 1.11739355 |
| 41 | MAP3K14 | 1.10816242 |
| 42 | TBK1 | 1.05248990 |
| 43 | DAPK2 | 1.03557698 |
| 44 | IRAK2 | 1.01514050 |
| 45 | LCK | 0.98476493 |
| 46 | SIK3 | 0.93665109 |
| 47 | PDK1 | 0.93339358 |
| 48 | CSF1R | 0.91934915 |
| 49 | PTK6 | 0.91805391 |
| 50 | MAP2K6 | 0.90846028 |
| 51 | KIT | 0.89974966 |
| 52 | MARK3 | 0.88178164 |
| 53 | NLK | 0.87919168 |
| 54 | MATK | 0.87215671 |
| 55 | SIK2 | 0.86416750 |
| 56 | ITK | 0.85361723 |
| 57 | PDPK1 | 0.84026430 |
| 58 | PTK2B | 0.83906538 |
| 59 | MARK2 | 0.80039953 |
| 60 | STK11 | 0.76388499 |
| 61 | TEC | 0.76217415 |
| 62 | MAP3K5 | 0.75461637 |
| 63 | DYRK1B | 0.74519147 |
| 64 | SGK2 | 0.71461336 |
| 65 | SGK3 | 0.71215390 |
| 66 | STK38 | 0.69503324 |
| 67 | MAP3K7 | 0.69143166 |
| 68 | ACVR1B | 0.68614639 |
| 69 | CAMKK2 | 0.67167745 |
| 70 | BMPR2 | 0.66849996 |
| 71 | PRKD2 | 0.65787177 |
| 72 | KSR1 | 0.63708218 |
| 73 | WNK1 | 0.62545522 |
| 74 | PRKAA2 | 0.62505157 |
| 75 | MAP3K13 | 0.62348743 |
| 76 | PRKCZ | 0.62324960 |
| 77 | LRRK2 | 0.61884800 |
| 78 | RET | 0.61747334 |
| 79 | TGFBR2 | 0.60787433 |
| 80 | FYN | 0.60078600 |
| 81 | PRKCQ | 0.60069034 |
| 82 | IKBKB | 0.60060458 |
| 83 | RAF1 | 0.58349617 |
| 84 | STK10 | 0.54746240 |
| 85 | OXSR1 | 0.51837765 |
| 86 | TAOK2 | 0.48213202 |
| 87 | MAPK12 | 0.47963663 |
| 88 | CDK19 | 0.46683060 |
| 89 | HIPK2 | 0.43507262 |
| 90 | SIK1 | 0.40945709 |
| 91 | SGK223 | 0.39814559 |
| 92 | SGK494 | 0.39814559 |
| 93 | PAK3 | 0.39656906 |
| 94 | TRIB3 | 0.38808166 |
| 95 | PRKG2 | 0.37945506 |
| 96 | PIM1 | 0.35972254 |
| 97 | PRKACG | 0.35330242 |
| 98 | CAMKK1 | 0.35266357 |
| 99 | CAMK4 | 0.34164032 |
| 100 | ERBB2 | 0.33285353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.08479941 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.78270047 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.26136159 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.13721052 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88023518 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.84152232 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.84102800 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71534966 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.49911854 |
| 10 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.44653534 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.28510182 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.09909564 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05935359 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86922824 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.81674377 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79141489 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71322096 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70293132 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69670405 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64645688 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63254932 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.56843920 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55846248 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48525342 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.47833131 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47372740 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35482102 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28565709 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22559299 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17662659 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.15010512 |
| 32 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10285713 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.07419134 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02477830 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01159413 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00597613 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99817919 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 0.98171815 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92873719 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92710639 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91179206 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 0.89283807 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.88012098 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86707609 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80407345 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.80382225 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80240038 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79579916 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76136268 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73509367 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72814915 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.72528651 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.72070736 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68213806 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67619092 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65849428 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64985863 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.63022400 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62456894 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61531724 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60325423 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59661309 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59350639 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.58506010 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57500484 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.57411137 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.56758071 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56015893 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55037504 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55020262 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54569911 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53706902 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52521387 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.52151533 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.51403001 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48681142 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46360928 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45519585 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45116756 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44443783 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43950248 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43142388 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39905859 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37401644 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32670043 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31835487 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31061341 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.31052797 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29465981 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29399704 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.28932449 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25797062 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.24992459 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23419595 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22569684 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.20941002 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19860755 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19641181 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18363548 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16945637 |

